Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on: March 30,2025

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on:March 30,2025

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on: December 22,2023

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on:December 22,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on: December 27,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on:December 27,2023

Thousands of cancer patients to trial personalised vaccines in England | BBC News

Updated on: August 28,2024

Thousands of cancer patients to trial personalised vaccines in England | BBC News

Updated on:August 28,2024

Parental alcohol use linked to increased cancer risk in children

Updated on: April 18,2025

Parental alcohol use linked to increased cancer risk in children

Updated on:April 18,2025

Gut microbes implicated in bladder cancer

byEuropean Molecular Biology LaboratoryA science illustrator depicts how the carcinogen BBN (left) is affected by gut bacteria and then metabolized to BCPN (right) and distributed in the body, l

Updated on: August 27,2024

Gut microbes implicated in bladder cancer

byEuropean Molecular Biology LaboratoryA science illustrator depicts how the carcinogen BBN (left) is affected by gut bacteria and then metabolized to BCPN (right) and distributed in the body, l

Updated on:August 27,2024

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Updated on: December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Updated on:December 22,2023

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK

Updated on: January 04,2024

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK

Updated on:January 04,2024

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat

Updated on: December 22,2023

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat

Updated on:December 22,2023

Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti

Updated on: May 26,2024

Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti

Updated on:May 26,2024